Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity.

Cancer letters - 1 Aug 2010

Zhu Hu, Cao Xinyu, Ali-Osman Francis, Keir Stephen, Lo Hui-Wen

Abstract excerpt

EGFR and its constitutively activated variant EGFRvIII are linked to glioblastoma resistance to therapy, the mechanisms underlying this association, however, are still unclear. We report that in glioblastoma, EGFR/EGFRvIII paradoxically co-expresses with p53-upregulated modulator of apoptosis (PUMA), a proapoptotic member of the Bcl-2 family of proteins primarily located on the mitochondria. EGFR/EGFRvIII binds...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis Regulatory Proteins
Share to Astrocytoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to DNA Transposable Elements

Share to Gefitinib

Share to Glioblastoma

Share to Quinazolines

Share to Transplantation, Heterologous

Source

Open in PubMed Open full text

Identifiers

PMID: 20153921
DOI: 10.1016/j.canlet.2010.01.028
PMCID: PMC2875288

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity.PMID 20153921Read ↗

Beyond effector caspase inhibitionSemantic proximity Read ↗

A Urokinase Receptor–Bim Signaling Axis Emerges during EGFR Inhibitor Resistance in Mutant EGFR GlioblastomaSemantic proximity Read ↗

Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor.Semantic proximity Read ↗

Puma, a critical mediator of cell death — one decade on from its discoverySemantic proximity Read ↗

The p53 Upregulated Modulator of Apoptosis (PUMA) Chemosensitizes Intrinsically Resistant Ovarian Cancer Cells to Cisplatin by Lowering the Threshold Set by Bcl-xL and Mcl-1Semantic proximity Read ↗

EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastomaSemantic proximity Read ↗

Opposing effect of EGFRWT on EGFRvIII-mediated NF-κB activation with RIP1 as a cell death switch.Semantic proximity Read ↗

Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.Semantic proximity Read ↗

EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.Semantic proximity Read ↗

Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma Multiforme through de-repression of Bcl-xL translationSemantic proximity Read ↗

BIM Is the Primary Mediator of MYC-Induced Apoptosis in Multiple Solid TissuesSemantic proximity Read ↗

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.